Federal health regulators are questioning the safety and evidence behind the first bid to use MDMA, the mind-altering club drug, as a treatment for PTSD, part of a decadeslong effort by advocates to move psychedelic drugs into the medical mainstream.

wikipedia

KIFI

Idaho Falls

Bonneville County

Idaho

United States

Psychedelic drug MDMA faces questions as FDA considers approval for PTSD

MDMA could be reclassified as a prescription medicine and made available to specially certified doctors and therapists

Ad Fontes Media

All Sides

Media Bias/Fact Check

The Independent

Evgeny Lebedev

London

Greater London

England

United Kingdom

The battle for MDMA as drug steps closer to becoming a prescription medicine

WASHINGTON (AP) — Federal health regulators are questioning the safety and evidence behind the first bid to use MDMA, the mind-altering club drug, as a treatment for PTSD, part of a decadeslong effort by advocates to move psychedelic drugs into the medical mainstream.The Food and Drug Administration posted its initial review of the drug Friday,...

Associated Press News

Independent Media

Federal health regulators are set to review the first request to approve the mind-altering club drug MDMA as a treatment for PTSD

abc News

The Walt Disney Company

By MATTHEW PERRONE
AP Health Writer WASHINGTON (AP) — Federal health regulators are set to review the first request to approve the mind-altering club drug MDMA as a treatment for PTSD. The Food and Drug Administration posted its review of the drug on Friday, raising questions about its effectiveness and potential risks, including heart problems. The drug application is part of a decadeslong effort by advocates to move psychedelic drugs into the …

News-Press & Gazette Company

Drugs such as LSD, ketamine, mushrooms and MDMA can be powerful treatments for severe depression and PTSD, mounting evidence suggests — but not everyone is convinced.

CBS News

National Amusements

Michael Redstone

Psychoactive drugs like ketamine and MDMA are having a moment. The FDA will soon weigh in.

WASHINGTON (AP) — Federal health regulators are questioning the safety and evidence behind the first bid to use MDMA, the mind-altering club drug, as a treatment for PTSD, part of […]

Winnipeg Free Press

Winnipeg

Manitoba

Canada

WASHINGTON (AP) — Federal health regulators are questioning the safety and evidence behind the first bid to use MDMA, the mind-altering club drug, as a treatment for PTSD, part of a decadeslong effort by advocates to move psychedelic drugs into the m

Flin Flon Reminder

Flin Flon

Rocky Mountain Outlook

Glacier Media

Federal health regulators are questioning the safety and evidence behind the first bid to use MDMA, the mind-altering club drug, as a treatment for PTSD, part of a decadeslong effort by advocates to move psychedelic drugs into the medical mainstream.The Food and Drug Administration posted its initial review of the drug Friday, ahead of a meeting of outside advisers who could help decide whether MDMA — currently illegal under federal law — become…

WPLG

Howard Buffett

Miami

Miami-Dade County

Florida

WKMG

Graham Holdings

Orlando

Orange County

Psychedelics

North America

Health

Mental Health

Medical

Portland Press Herald

Airdrie City View

Medical Xpress

PBS NewsHour

WGN 9

NBC LA

Daily Camera

Morning Sun

Military.com

Ars Technica

pantheonsite.io

KFOR FM 103.3 1240 AM

castanet.net

Psychedelic drug MDMA faces questions as FDA considers approval for PTSD

Coverage Details

Give the gift of Perspective

Bias Distribution

Ownership

Similar News Topics

Similar News Topics